(24/7 MARKET NEWS) – Biotricity Inc. (NASDAQ: BTCY) announced, this morning, that it signed its second distribution agreement with a top five US medical device distributor for the marketing and distribution of its two cardiac monitoring solutions (CMS) designed for cardiologists’ patient use – Bioflux® and BiotresTM.
Biotricity is trading at $0. 8169, up $0.0737 (+9.92%), on volume of 820 thousand shares traded.
Its 52-week range is $0.3992 to 3.40. The next key inflection points are $0.98 and $1.02. If can trade above $1,02, on strong volume, it could try to challenge the $1.50 trading level.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.
Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.